At this EAACI 2025 symposium, experts discuss CRSwNP and Severe Asthma, the associated patient burden, and explore the role ...

The United States Food and Drug Administration (FDA) has suspended the license for Valneva's chikungunya vaccine Ixchiq with ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Under the NYSE's rules, the Company can regain compliance with this NYSE listing standard by filing the Form 10-Q with the SEC before February 19, 2026. In accordance with the NYSE notice, the Company ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist, previously approved as IMCIVREE ® by the FDA, the EMA, and UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) for obesity due to ...

Medication abortion is now the dominant method in Connecticut, with mifepristone used in nearly 70 percent of abortions in ...

(Reuters) -Shares in Valneva slumped around 25% on Monday after the French drugmaker said the United States Food and Drug ...

TERN-701 is an investigational next-generation oral, allosteric BCR-ABL inhibitor specifically targeting the ABL myristoyl pocket that is being evaluated for the treatment of CML.

Addiction survivor Kaleb Allshouse, 32, died in his van hours after buying an 7-OH tablet for $8. His death underscores FDA ...

NI Holdings, Inc. had 20,675,337 shares of common stock outstanding as of July 31, 2025, per the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2025.

Hydroxymitragynine, is a semi-synthetic compound extracted from Kratom leaves. Kratom historically comes from Southeast Asia.

All required regulatory approvals related to the proposed merger have been received. <li /> Proposed merger closing is expected to be c ...